Cardiovascular Atlas
About
Menu

Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

October 2026 1

  1. Primary completion ORION-4 (inclisiran outcome trial)

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

April 2029 1

  1. Study completion TRILUMINATE Pivotal trial

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: TRILUMINATE Pivotal Trial

June 2029 1

  1. Study completion Evolut Low Risk trial

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

December 2029 1

  1. Study completion PARTNER 3 trial

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

March 2032 1

  1. Study completion EARLY TAVR

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

December 2049 1

  1. Study completion ORION-4 (inclisiran outcome trial)

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion COAPT trial

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS